Performance of NucliSens HIV-1 EasyQ version 2.0 compared with six commercially available quantitative nucleic acid assays for detection of HIV-1 in China

Molecular Diagnosis and Therapy

Volumn 14, Issue 5, 2010, Pages 305-316

  Xu, Sihong ^a   Song, Aijing ^a   Nie, Jianhui ^a   Li, Xiuhua ^a   Wang, Youchun ^a  

^a NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD SAMPLING; CHINA; CLADISTICS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENE AMPLIFICATION; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERMETHOD COMPARISON; NONHUMAN; NUCLEIC ACID ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; VIRUS DETECTION; VIRUS LOAD;

BIOLOGICAL ASSAY; CHINA; GENOTYPE; HIV-1; HUMANS; REAGENT KITS, DIAGNOSTIC; RNA, VIRAL;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 78149397664     PISSN: 11771062     EISSN: 11792000     Source Type: Journal    
DOI: 10.2165/11585000-000000000-00000     Document Type: Article

References (49)

1. World Health Organization [WHO]. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach [2010 revision]. Geneva: WHO, 2010 [online]. Available from URL: http://www.who.int/ hiv/pub/arv/adult2010/en/index.html [Accessed 2010 Oct 5]
2. MacDougall DS. Quantitative measurement of HIV RNA: techniques & clinical applications. J Int Assoc Physicians AIDS Care 1996; 2: 9-14
3. Peter JB, Blum RA. Monitoring HIV viral loads in the United States: recent trends and methodologies. J Acquir Immune Defic Syndr 2002; 30: 261-2
4. Saag MS, HolodniyM, Kuritzkes DR, et al. HIV viral load markers in clinical practice. Nat Med 1996; 2: 625-9
5. Swanson P, Holzmayer V, Huang S, et al. Performance of the automated Abbott RealTime™ HIV-1 assay on a genetically diverse panel of specimens from London: comparison to Versant HIV-1 RNA 3.0, Amplicor HIV-1 Monitor V2.5, andLCxHIVRNAQuantitative assays. JVirolMethods 2006; 137: 184-92
6. Kievits T, van Gemen B, van Strijp D, et al. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J Virol Methods 1991; 35: 273-86
7. van Gemen B, Kievits T, Schukkink R, et al. Quantification of HIV-1 RNA in plasma using NASBA duringHIV-1 primary infection. J VirolMethods 1993; 43: 177-87
8. Tyagi S, Bratu DP, Kramer FR. Multicolor molecular beacons for allele discrimination. Nat Biotechnol 1998; 16: 49-53
9. Katsoulidou A, Petrodaskalaki M, Sypsa V, et al. Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: comparison of the new Cobas TaqMan HIV-1 with three current HIV-RNA assays - LCx HIV RNA quantitative, Versant HIV-1 RNA 3.0 (bDNA) and Cobas Amplicor HIV-1 Monitor V2.5. J Virol Methods 2006; 131: 168-74
10. Oliver AR, Pereira SF, Clark DA. Comparative evaluation of the automated Roche TaqMan real-time quantitative human immunodeficiency virus type 1 RNA PCR assay and the Roche Amplicor Version 1.5 conventional PCR assay. J Clin Microbiol 2007; 45: 3616-9
11. Perrin L, Pawlotsky JM, Bouvier-Alias M, et al. Multicenter performance evaluation of a new TaqMan PCR assay for monitoring human immunodeficiency virus RNA load. J Clin Microbiol 2006; 44: 4371-5
12. de Mendoza C, Koppelman M, Montes B, et al. Multicenter evaluation of the NucliSens EasyQ HIV-1 V2.1 assay for the quantitative detection of HIV-1 RNA in plasma. J Virol Method 2005; 127: 54-9
13. Gottesman BS, Grossman Z, Lorber M, et al. Comparative performance of the Amplicor HIV-1 Monitor assay versus NucliSens EasyQ in HIV subtype C-infected patients. J Med Virol 2006; 78: 883-7
14. Stevens W, Horsfield P, Scott LE. Evaluation of the performance of the automated NucliSens easyMAG and EasyQ systems versus the Roche AmpliPrep-Amplicor combination for high-throughput monitoring of human immunodeficiency virus load. J Clin Microbiol 2007; 45: 1244-9
15. Stevens W, Wiggill T, Horsfield P, et al. Evaluation of the NucliSens EasyQ assay in HIV-1-infected individuals in South Africa. J VirolMethods 2005; 124: 105-10
16. Garcia-Diaz A, Clewley GS, Booth CL, et al. Comparative evaluation of the performance of the Abbott real-time human immunodeficiency virus type 1 (HIV-1) assay for measurement of HIV-1 plasma viral load following automated specimen preparation. J Clin Microbiol 2006; 44: 1788-91
17. Swanson P, Huang S, Abravaya K, et al. Evaluation of performance across the dynamic range of the Abbott RealTime- HIV-1 assay as compared to VersantHIV-1RNA3.0 and Amplicor HIV-1Monitor V2.5 using serial dilutions of 39 group M and O viruses. J Virol Methods 2007; 141: 49-57
18. Swanson P, Huang S, Holzmayer V, et al. Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from Brazil. J Virol Methods 2006; 134: 237-43
19. Xu S, Song A, Nie J, et al. Comparative evaluation of the Cobas Ampli-Prep/Cobas TaqMan HIV type 1 test (CAP/CTM) and Versant HIV type 1 RNA 3.0 assay (bDNA) for quantifying HIV type 1 viral loads in China. AIDS Res Hum Retroviruses 2008; 24: 1365-73
20. Xu S, Song A, Li X, et al. Performance of the Abbott RealTime™ HIV-1 assay for quantitation ofHIV-1 clades prevalent inChina. J Clin Virol 2008; 41: 305-9
21. Yao J, Liu Z, Ko L-S, et al. Quantitative detection of HIV-1 RNA using NucliSens EasyQ HIV-1 assay. J Virol Methods 2005; 129: 40-6
22. Wang Y, Song A, Xu S, et al. Impact of HIV-1 genetic diversity in China on the measurement of viral load. J Med Virol 2008; 80: 1-8
23. Braun P, Ehret R, Wiesmann F, et al. Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routine. Clin Chem Lab Med 2007; 45: 93-9
24. Gill MJ, Beckthold B, Church D, et al. The impact of genetic diversity on viral load quantification [abstract no. TUPEB059]. 4th IAS Conference on HIV Pathogesis, Treatment and Prevention; 2007 Jul 22-25; Sydney
25. Gueudin M, Plantier JC, Lemeé V, et al. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J Acquir Immune Defic Syndr 2007; 44: 500-5
26. Drexler JF, de Souza Luna LK, et al. Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil. J Clin Microbiol 2007; 45: 2061-203
27. Geelen S, Lange J, Borleffs J, et al. Failure to detect a non-B HIV-1 subtype by the HIV-1 Amplicor monitor test, Version 1.5: a case of unexpected vertical transmission. AIDS 2003; 17: 781-2
28. Plantier JC, Leoz M, Dickerson JE, et al. A new human immunodeficiency virus derived from gorillas. Nat Med 2009; 15: 871-2
29. Fraf M, Shao Y, Zhao Q, et al. Cloning and characterization of a virtually fulllength HIV type 1 genome from a subtype B0-Thai strain representing the most prevalent B-clade isolate in China. AIDS Res Hum Retrovir 1998; 14: 285-8
30. Piyasirisilp S, McCutchan FE, Carr JK, et al. A recent outbreak of human immunodeficiency virus type 1 in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J Virol 2000; 74: 11286-95
31. National Center for Biotechnology Information, National Library of Medicine. Genotyping [online]. Available from URL: http://www.ncbi.nlm.nih.gov/ projects/genotyping [Accessed 2010 Oct 4]
32. Stevens W, Scott LE, Crowe SM. Quantifying HIV for monitoring antiretroviral therapy in resource-poor settings. J Infect Dis 2010; 201 Suppl. 1: S16-26
33. Sun R, Ku J, Jayakar H, et al. Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 1998; 36: 2964-9
34. Holmes H, Davis C, Heath A, et al. An international collaborative study to establish the 1st international standard for HIV-1 RNA for use in nucleic acid-based techniques. J Virol Methods 2001; 92: 141-50 (Pubitemid 32171982)
35. Van Deursen P, Oosterlaken T, Andre P, et al. Measuring human immunodeficiency virus type 1 RNA loads in dried blood spot specimens using NucliSens EasyQ HIV-1 V2.0. J Clin Virol 2010; 47: 120-5
36. Yen-Lieberman B, Brambilla D, Jackson B, et al. Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories. J Clin Microbiol 1996; 34: 2695-701
37. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-10
38. Amendola A, Bordi L, Angeletti C, et al. Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02). J Acquir Immune Defic Syndr 2002; 31: 488-94
39. Burgisser P, Vernazza P, FleppM, et al. Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. J Acquir Immune Defic Syndr 2000; 23: 138-44
40. Holguín A, De Mendoza C, Soriano V. Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes. Eur J Clin Microbiol Infect Dis 1999; 18: 256-9
41. Jagodzinski LL, Wiggins DL, McManis JL, et al. Use of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 to assess the performance of viral RNA quantitation tests. J Clin Microbiol 2000; 38: 1247-9
42. Murphy DG, Côté L, Fauvel M, et al. Multicenter comparison ofRoche Cobas AmplicorMonitorVersion 1.5,OrganonTeknikaNucliSensQTwithExtractor, and Bayer Quantiplex Version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma. J ClinMicrobiol 2000; 38: 4034-41
43. Nkengasong JN, Bile C, Kalou M, et al. Quantification of RNA in HIV type 1 subtypesDandGby NucliSens and Amplicor assays in Abidjan, Ivory Coast. AIDS Res Hum Retrovir 1999; 15: 495-8
44. Nkengasong JN, Kalou M, Maurice C, et al. Comparison of NucliSens and Amplicor Monitor assays for quantification of human immunodeficiency virus type 1 (HIV-1) RNA in plasma of persons with HIV-1 subtype A infection in Abidjan, Côte d'Ivoire. J Clin Microbiol 1998; 36: 2495-8
45. Segondy M, Ly TD, LapeyreM, et al. Evaluation of the NucliSens HIV-1 QT assay for quantitation of human immunodeficiency virus type 1RNAlevels in plasma. J Clin Microbiol 1998; 36: 3372-4
46. Schumacher W, Frick E, KauselmannM, et al. Fully automated quantification of human immunodeficiency virus (HIV) type 1RNAin human plasma by the Cobas AmpliPrep/Cobas TaqMan system. J Clin Virol 2007; 38: 304-12
47. Lam HY, Chen JHK, Wong KH, et al. Evaluation of NucliSens EasyQ™ HIV-1 assay for quantification of HIV-1 subtypes prevalent in South-east Asia. J Clin Virol 2007; 38: 39-43
48. Swanson P, de Mendoza C, Joshi Y, et al. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, Amplicor HIV-1 Monitor V2.5, Versant HIV-1 RNA 3.0, and NucliSens HIV-1 QT. J Clin Microbiol 2005; 43: 3860-8
49. Antunes R, Figueiredo S, Bartolo I, et al. Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtypeG and BG recombinant forms. J Clin Microbiol 2003; 41: 3361-7